Lorcainide hydrochloride is a medication mainly used to treat heart rhythm disorders (arrhythmias). Specifically, it’s used to manage ventricular arrhythmias, including premature ventricular contractions and ventricular tachycardia, and sometimes supraventricular arrhythmias like those associated with Wolff-Parkinson-White syndrome. It works by affecting how electrical signals travel through the heart, helping to restore a normal heart rhythm. Its therapeutic use is listed as antiarrhythmics. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Socainide hydrochloride, Remivox, Lopantrol and Lorivox. Its PubChem CID is 6917855.
Lorcainide hydrochloride
| CAS No | 58934-46-6 |
|---|---|
| Molecular Formula | C22H28Cl2N2O |
| Molecular Weight | 407.40 g/mol |
| Synonyms | N-(4-chlorophenyl)-2-phenyl-N-(1-propan-2-ylpiperidin-4-yl)acetamide;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Lorcainide hydrochloride is a medication mainly used to treat heart rhythm disorders (arrhythmias).
The listed CAS number is 58934-46-6.
The listed molecular formula is C22H28Cl2N2O.
The listed molecular weight is 407.40 g/mol.
N-(4-chlorophenyl)-2-phenyl-N-(1-propan-2-ylpiperidin-4-yl)acetamide;hydrochloride.
The source lists Socainide hydrochloride, Remivox, Lopantrol and Lorivox.